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Angioplasty balloon positioning and inflation test. Before the
operation, the patients were transferred to the cardiac catheteriza-
tion laboratory. Coronary angiography was performed via the left
brachial artery. Selective catheterization of the LITA graft demon-
strated perfect patency. An angioplasty balloon (Gemini 2.5
mm/15 mm; ACS Guidant, Indianapolis, Ind) was positioned in the
median portion of the graft via a wire (BMW 0.014; ACS Guidant),
which was left in the coronary network. The graft was transiently
occluded by inflating the balloon to 4 atm. Both the balloon and
guidewire were left in place under full heparinization and the
patient was transferred to the operating room.
Surgical Procedures
PATIENT 1. The patient was positioned in the decubitus position.
The right side was raised 45° with the left arm accessible. Surgery
was performed through a right anterolateral thoracotomy in the
fourth intercostal space. Cardiopulmonary bypass (CPB) was initi-
ated between a double-stage venous cannula (Carpentier bicaval
femoral cannula; DLP, Inc, Grand Rapids, Mich; Medtronic, Inc,
Minneapolis, Minn) inserted through the right femoral vein and a
right femoral arterial cannula. The venae cavae were snared.
Simultaneous to aortic crossclamping, the LITA-LAD graft flow
was interrupted by angioplasty balloon inflation and cardioplegic
solution was injected via the aortic root. The tumor was then
excised via a transseptal approach (Figure 3). Total CPB time was
32 minutes, and both aortic crossclamp and LITA occlusion times
were 21 minutes, with spontaneous recovery of cardiac function.
The postoperative course was uneventful, with no increase in car-
diac enzymes or modifications of the electrocardiogram.
From the Department of Cardiovascular Surgery, Hôpital Européen Georges
Pompidou (HEGP), Paris, France.
Received for publication Sept 25, 2000; accepted for publication Oct 24, 2000.
Address for reprints: Jean-Michel Grinda, MD, Department of Cardiovascular
Surgery, Hôpital Européen Georges Pompidou (HEGP), 20, rue Leblanc, 75908
Paris, Cedex 15, France (E-mail: jean_michel.grinda@egp.ap_hop_paris.fr).
J Thorac Cardiovasc Surg 2001;122:182-3
Copyright © 2001 by The American Association for Thoracic Surgery
0022-5223/2001 $35.00 + 0 12/54/113015
doi:10.1067/mtc.2001.113015
Angioplasty balloon occlusion of internal thoracic artery in redo
surgery in patients with coronary artery bypass operations
J. M. Grinda, MD, C. P. Latremouille, MD, PhD, N. D’Attellis, MD, A. Berrebi, MD, and J. N. Fabiani, MD,  
Paris, France
TX
ET
CS
P
A
CD
CH
D
G
TS
ED
IT
O
RI
A
L
Redo cardiac procedures have become increasingly com-mon practice in most cardiac centers. During such redooperations, the presence and control of a patent internalthoracic artery–left anterior descending (ITA-LAD)
graft during dissection of the cardiac mass remains a problem.
Hypothermic fibrillation without aortic crossclamping can be a
useful technique. Surgeons who are reluctant to use this technique
usually clamp the ITA graft during aortic crossclamping to ensure
optimal myocardial arrest and protection. Surgical dissection, con-
trol, and clamping of an ITA graft involve inherent risk, which may
affect outcome.1 Endoluminal control of a patent ITA-LAD graft is
an interesting alternative to other conventional median sternotomy
approaches.
Clinical Summaries
History
PATIENT 1. A 72-year-old man was referred in March 1999 for a left
atrial tumor 4 years after coronary artery bypass grafting (CABG)
with a single left ITA (LITA)-LAD graft performed during the pre-
operative work-up of an abdominal aortic aneurysm. Recovery
from the 2 operations was uneventful. The left atrial tumor was dis-
covered by echocardiography during postoperative follow-up. A
spiral computed tomographic scan provided a precise image of the
tumor; it had a maximum diameter of 26 mm and was homoge-
neous, noncalcified, and attached by a pedicle to the atrial septum.
To avoid the risks associated with dissection of the LITA-LAD
graft, we decided to use endoluminal control of the graft and a sur-
gical approach by a right thoracotomy (Figure 1).
PATIENT 2. A 72-year-old man was referred in July 1999 for aor-
tic valve replacement 5 years after undergoing 3 CABGs (LITA-
LAD and 2 saphenous grafts on the right coronary and the mar-
ginal arteries). Preoperative coronary angiography showed that all
the grafts were patent. We chose to use a ministernotomy and
endoluminal control of the LITA-LAD graft (Figure 2). 
Figure 1. Proposed right anterolateral thoracotomy, the double-
stage venous cannula, and control of the LITA graft by angioplas-
ty balloon for myxoma removal.
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Pathologic examination confirmed the diagnosis of myxoma. At 18
months’ follow-up the patient is doing well.
PATIENT 2. The patient was positioned in the dorsal decubitus
position, with the left arm accessible. The operation was per-
formed through a superior longitudinal ministernotomy extending
to the fourth intercostal space (ministernotomy in a J shape). CPB
was instituted between a double-stage venous cannula (Carpentier
bicaval femoral cannula; DLP and Medtronic) inserted through the
right femoral vein and an ascending aortic cannula. Only the
ascending aorta was dissected. Simultaneous to aortic balloon
inflation, cardioplegic solution was injected via the aortic root. The
aorta was opened so as to not injure the proximal anastomosis of
the saphenous graft. A vent was directly positioned in the left ven-
tricle through the aortic orifice. The aortic valve was resected and
a double-leaflet mechanical prosthesis was inserted. Total CPB
time was 44 minutes, and both aortic crossclamp and LITA occlu-
sion times were 35 minutes, with spontaneous recovery of cardiac
function. The postoperative course was uneventful, with no
increase in cardiac enzymes or modifications of the electrocardio-
gram. At 12 months’ follow-up the patient is doing well.
Discussion
A patent ITA graft is undoubtedly a problem in the event of redo
cardiac surgery. Surgical control of patent ITA grafts is usual when
only the posterolateral wall must be revascularized during redo
CABG. Nevertheless, surgical control of the patent ITA graft
should be avoided during redo surgery for valvular or tumoral dis-
ease, more so than when other conventional median sternotomy
approaches can be used.
We routinely perform operations on the atrioventricular valves
or atrial septum through a right anterolateral thoracotomy2 and
aortic valve replacement as well as redo aortic valve replacement
through a J-shaped ministernotomy. The use of endoluminal con-
trol of a patent LITA-LAD graft further extends the indications of
this surgical approach to patients who have previously undergone
a bypass procedure with a LITA-LAD graft.
Most reports concerning angioplasty and ITA grafts focus on
dilatation of anastomotic sites or the graft itself or else on accessi-
bility to the coronary network via the graft.3,4 Little information is
available concerning the potential risks of endothelial damage and
potential long-term consequence, for example, late stenosis or
occlusion, that can occur with prolonged endoluminal occlusion of
an ITA graft. The choice of size of the angioplasty balloon was
based on the size of the ITA graft, and previous inflation tests per-
mitted the determination of the minimal amount of inflation ensur-
ing interruption of blood flow through the graft without excessive
pressure on the intima. In these conditions, the risk of endoluminal
occlusion appears comparable with that of external graft clamping
and the preferred endoluminal control is, in our opinion, justified
by the advantages described herein.
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Figure 2. Proposed J-shaped ministernotomy and control of the
LITA graft by angioplasty balloon for aortic valve replacement.
Figure 3. Proposed endoluminal occlusion of the LITA simultane-
ous to aortic crossclamping and myxoma removal through a
transseptal approach.
